Beyond germline pathogenic variants (gPVs) in breast cancer genes 1 and 2 (BRCA1/2), alterations in BRIP1, RAD51C, and RAD51D and mismatch repair (MMR) genes also enhance EOC risk. The gene discussed is BRCA1; the disease is breast carcinoma.